H. Karanlik Et Al. , "Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy," 9th European Breast Cancer Conference (EBCC) , vol.50, Glasgow, United Kingdom, 2014
Karanlik, H. Et Al. 2014. Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy. 9th European Breast Cancer Conference (EBCC) , (Glasgow, United Kingdom).
Karanlik, H., Saip, P., Fayda, M., Yavuz, E., Eralp, Y., Kucucuk, S., ... Kurul, S.(2014). Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy . 9th European Breast Cancer Conference (EBCC), Glasgow, United Kingdom
Karanlik, H. Et Al. "Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy," 9th European Breast Cancer Conference (EBCC), Glasgow, United Kingdom, 2014
Karanlik, H. Et Al. "Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy." 9th European Breast Cancer Conference (EBCC) , Glasgow, United Kingdom, 2014
Karanlik, H. Et Al. (2014) . "Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy." 9th European Breast Cancer Conference (EBCC) , Glasgow, United Kingdom.
@conferencepaper{conferencepaper, author={H. Karanlik Et Al. }, title={Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy}, congress name={9th European Breast Cancer Conference (EBCC)}, city={Glasgow}, country={United Kingdom}, year={2014}}